Curative testing site partnership provides patients who test positive access to antiviral pill
Curative has announced a new partnership that will give those who test positive for COVID-19 access to antiviral treatment, including the antiviral COVID-19 pill.
AUSTIN (KXAN) — Curative has announced a new partnership that will give those who test positive for COVID-19 access to antiviral treatment, including the antiviral COVID-19 pill.
Curative's partnership with Truepill was announced in early April. Patients who test positive after taking a COVID-19 molecular or antigen test at a Curative testing site will be offered a chance to take advantage of Truepill's virtual care platform, including telehealth, and an antiviral prescription will be sent to their door, if eligible.
Truepill provides antiviral treatment with emergency use authorization: PAXLOVID and Molnupiravir.
Newly-infected COVID-19 patients will have to take the pills as soon as possible once symptoms appear.
In high-risk patients, both antiviral pills were shown to reduce the chances of hospitalization or death from COVID-19.
To find a COVID-19 testing site near you, visit Curative's website.